Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 48

References for PMC Articles for PubMed (Select 19174434)

1.

Perspectives on hormone replacement therapy: the Women's Health Initiative and new observational studies sampling the overall population.

Tannen RL, Weiner MG, Xie D, Barnhart K.

Fertil Steril. 2008 Aug;90(2):258-64. doi: 10.1016/j.fertnstert.2008.05.031.

2.
4.

In defense of pharmacoepidemiology--embracing the yin and yang of drug research.

Avorn J.

N Engl J Med. 2007 Nov 29;357(22):2219-21. No abstract available.

PMID:
18046025
5.

A simulation using data from a primary care practice database closely replicated the women's health initiative trial.

Tannen RL, Weiner MG, Xie D, Barnhart K.

J Clin Epidemiol. 2007 Jul;60(7):686-95. Epub 2006 Dec 27.

PMID:
17573984
6.

Hormone therapy and coronary heart disease in young women.

Weiner MG, Barnhart K, Xie D, Tannen RL.

Menopause. 2008 Jan-Feb;15(1):86-93.

PMID:
17502840
7.

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML.

JAMA. 2007 Apr 4;297(13):1465-77. Erratum in: JAMA. 2008 Mar 26;299(12):1426.

PMID:
17405972
8.

Invited commentary: advancing propensity score methods in epidemiology.

Oakes JM, Church TR.

Am J Epidemiol. 2007 May 15;165(10):1119-21; discussion 1122-3. Epub 2007 Mar 28.

9.

Performance of propensity score calibration--a simulation study.

Stürmer T, Schneeweiss S, Rothman KJ, Avorn J, Glynn RJ.

Am J Epidemiol. 2007 May 15;165(10):1110-8. Epub 2007 Mar 28.

10.

Estrogen affects post-menopausal women differently than estrogen plus progestin replacement therapy.

Tannen RL, Weiner MG, Xie D, Barnhart K.

Hum Reprod. 2007 Jun;22(6):1769-77. Epub 2007 Mar 8.

12.

Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable.

Brookhart MA, Wang PS, Solomon DH, Schneeweiss S.

Epidemiology. 2006 May;17(3):268-75.

13.

Instrumental variables: application and limitations.

Martens EP, Pestman WR, de Boer A, Belitser SV, Klungel OH.

Epidemiology. 2006 May;17(3):260-7.

PMID:
16617274
14.

Simulation of the Syst-Eur randomized control trial using a primary care electronic medical record was feasible.

Tannen RL, Weiner MG, Marcus SM.

J Clin Epidemiol. 2006 Mar;59(3):254-64.

PMID:
16488356
15.

When are observational studies as credible as randomised trials?

Vandenbroucke JP.

Lancet. 2004 May 22;363(9422):1728-31. No abstract available.

PMID:
15158638
16.

Beyond randomised versus observational studies.

Concato J, Horwitz RI.

Lancet. 2004 May 22;363(9422):1660-1. No abstract available.

PMID:
15158623
17.

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S; Women's Health Initiative Steering Committee.

JAMA. 2004 Apr 14;291(14):1701-12.

PMID:
15082697
18.

Approaches to combat with confounding by indication in observational studies of intended drug effects.

McMahon AD.

Pharmacoepidemiol Drug Saf. 2003 Oct-Nov;12(7):551-8.

PMID:
14558178
19.

Evaluating non-randomised intervention studies.

Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG; International Stroke Trial Collaborative Group; European Carotid Surgery Trial Collaborative Group.

Health Technol Assess. 2003;7(27):iii-x, 1-173. Review.

20.

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

Fox KM; EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators.

Lancet. 2003 Sep 6;362(9386):782-8.

PMID:
13678872
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk